Atlas Trials

Bladder Perfusion of Plasma-Activated Saline for Bladder Cancer

Clinical trial NCT07272603 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07272603
Sponsor
Qilu Hospital of Shandong University
Status
NOT_YET_RECRUITING
Phase
Early Phase 1
Study type
INTERVENTIONAL
Bladder (Urothelial, Transitional Cell) Cancer
Start date
2025-12-15
Primary completion
2026-02-15
Enrollment
5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.